The condensed balance sheets for kaléo at September 30, 2016 and December 31, 2015 and condensed statements of operations for the three and nine months ended September 30, 2016 and 2015, as reported to the Company by kaléo, are provided below:



(In Thousands)	September 30, 2016		December 31, 2015			September 30, 2016			December 31, 2015
Assets:					Liabilities & Equity:
Cash & short-term investments	$	111,305	$	91,844
Restricted cash	30		8,182
Other current assets	16,361		9,070		Current liabilities	$	54,434		$	10,261
Property & equipment	14,072		8,453		Long term debt, net	143,212			142,696
Patents	2,865		2,811		Other noncurrent liabilities	767			552
Other long-term assets	93		92		Equity	(53,687		)	(33,057		)
Total assets	$	144,726	$	120,452	Total liabilities & equity	$	144,726		$	120,452



	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Revenues & Expenses:
Revenues, net	$	17,377		$	28,084		$	29,347		$	43,002
Cost of goods sold	(2,956		)	(3,438		)	(10,564		)	(8,575		)
Expenses and other, net (a)	(22,216		)	(17,337		)	(39,815		)	(45,727		)
Income tax benefit (expense)	—			—			(8		)	(4		)
Net income (loss)	$	(7,795	)	$	7,309		$	(21,040	)	$	(11,304	)
(a) “Expenses and other, net” includes selling, general and administrative expense, research and development expense, gain on contract termination, interest expense and other income (expense), net. Excluding the gain on contract termination, “Expenses and other, net” would have been a net deduction of $22.2 million and $57.9 million in the third quarter and first nine months of 2016, respectively.